⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LENZ News
LENZ Therapeutics, Inc. Common Stock
LENZ Therapeutics and Arrotex Pharmaceuticals Announce Exclusive License and Commercialization Agreement for VIZZ™ in Australia and New Zealand
globenewswire.com
LENZ
Form 8-K
sec.gov
LENZ
LENZ Therapeutics Announces Everest Medicines Acquired Rights to Develop and Commercialize VIZZ® (LNZ100) in Greater China
globenewswire.com
LENZ
LENZ Therapeutics to Participate in Upcoming Investor Conferences
globenewswire.com
LENZ
Form 8-K
sec.gov
LENZ
LENZ Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Highlights
globenewswire.com
LENZ
LENZ Therapeutics to Report First Quarter 2026 Financial Results and Recent Corporate Highlights on May 11, 2026 and Attend Upcoming Investor Conference
globenewswire.com
LENZ
LENZ Therapeutics, Inc. Investigated by the Portnoy Law Firm
globenewswire.com
LENZ
LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom
globenewswire.com
LENZ
Form 8-K
sec.gov
LENZ